About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Use of Statins Among Lung Cancer Patients Reduces Risk of Death from the Disease

by Dr. Trupti Shirole on May 5, 2015 at 7:02 AM
Use of Statins Among Lung Cancer Patients Reduces Risk of Death from the Disease

Recently there has been an increasing interest in exploring new therapeutic uses of existing drugs, in part, because existing medications are relatively inexpensive and have known side effect profiles. Statins is a class of drugs often prescribed to help lower the blood cholesterol levels. Scientists have now discovered that prolonged use of statins may reduce the risk of death from lung cancer.

The study investigated whether lung cancer patients who received statins had improved cancer outcomes. Researchers used data from nearly 14,000 patients newly diagnosed with lung cancer between 1998 and 2009 from English cancer registry data.

Advertisement

Among patients who survived at least six months after a diagnosis, those who used statins after a lung cancer diagnosis had a statistically non-significant 11% reduction in lung cancer-specific deaths. Among those who used at least 12 prescriptions of statins there was a statistically significant 19% reduction in lung cancer-specific deaths, and among those who used lipophilic statins such as simvastatin there was a 19% reduction in lung cancer-specific deaths as well. Among all patients in the study, those who used statins in the year before a lung cancer diagnosis had a statistically significant 12% reduction in lung cancer-specific deaths.

Author Chris Cardwell from Queen's University Belfast in Northern Ireland said, "The outcomes were not different between non-small cell lung cancer patients and small cell lung cancer patients in this study. The study provided some evidence that lung cancer patients who used statins had a reduction in the risk of death from lung cancer. The magnitude of the association was relatively small and, as with all observational studies, there was the possibility of confounding, meaning that simvastatin users may have differed from simvastatin non-users in other ways that could have protected them from death from cancer, for which they could not correct."

The study appears in Cancer Epidemiology, Biomarkers and Prevention.

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 Genes Linked to Aggressive Prostate Cancer
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Link Between Poor Oral Health and Head & Neck Cancer Survival Uncovered
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Use of Statins Among Lung Cancer Patients Reduces Risk of Death from the Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests